What are the Key Challenges in Nanotechnology Targeting?
Despite the promising potential, several challenges must be addressed:
Biocompatibility: Ensuring that the nanoparticles do not elicit an adverse immune response. Stability: Maintaining nanoparticle stability in the bloodstream to prevent premature degradation or clearance. Specificity: Achieving high specificity to target cells while minimizing off-target effects. Scalability: Developing scalable and cost-effective production methods for clinical applications.
